Upstream Bio, Inc. Cash Flow Statement

Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -35.95M-65.64M
Depreciation and Depletion 0.06M0.09M
Share-based Compensation 3.43M6.00M
Gains from Investment Securities 4.17M6.49M
Non-cash Items 4.65M71.27M
Cash from Operations -37.93M-59.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.26M1.66M
Depreciation & Amortization (CF) 0.06M0.09M
Change in Working Capital
Change in Receivables -0.31M0.52M
Change in Account Payables 1.28M2.02M
Change in Accured Expenses 0.42M1.51M
Investing Activities
Capital Expenditures 0.14M0.51M
Change in Acquisitions & Divestments 46.29M231.63M
Cash from Investing Activities -82.84M-59.48M
Financing Activities
Change in Capital Stock
Shares Issued 0.12M272.72M
Preferred Shares Issued 80.00M149.92M
Misc.
Cash from Financing Activities 129.55M418.91M
Change in Cash 8.78M300.25M
Free Cash Flow -38.07M-59.68M
Net Cash Flow 8.78M300.25M